Literature DB >> 8027354

Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens.

R Vornhagen1, B Plachter, W Hinderer, T H The, J Van Zanten, L Matter, C A Schmidt, H H Sonneborn, G Jahn.   

Abstract

DNA fragments from eight different reading frames of human cytomegalovirus (HCMV) were generated by PCR and subsequently cloned and expressed in Escherichia coli in fusion with glutathione S-transferase. The recombinant viral antigens were evaluated in immunoblot analyses. The most reactive antigens were purified and further evaluated in ELISAs. For this, sera from healthy blood donors and immunocompetent individuals with acute HCMV infection, and follow-up sera from transplant recipients with acute primary HCMV infection were used. The results of our experiments indicate that only three particular recombinant polypeptides from two viral proteins are necessary for serodiagnosis. While a fragment covering amino acids (aa) 495 to 691 of pp150 (150/1) was the most suitable antigen for the identification of infected individuals in general, immunoglobulin M antibodies against the C-terminal parts of pp150 (aa 862 to 1048; 150/7) and p52 (aa 297 to 433; 52/3) proved to be excellent serological markers to monitor acute HCMV infection. The selected recombinant antigens enable the improvement of serodiagnosis of HCMV-related diseases, especially during the early stages of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027354      PMCID: PMC267166          DOI: 10.1128/jcm.32.4.981-986.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

Review 1.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.

Authors:  M Van der Giessen; A P van den Berg; W van der Bij; S Postma; W J van Son; T H The
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

3.  The structure of the major immediate early gene of human cytomegalovirus strain AD169.

Authors:  A Akrigg; G W Wilkinson; J D Oram
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

4.  Detection of antibody to cytomegalovirus-induced early antigens and comparison with four serologic assays and presence of viruria in blood donors.

Authors:  E B Lentz; N L Dock; C A McMahon; S R Fiesthumel; C B Arnold; H V Lamberson
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

5.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

6.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

7.  Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses.

Authors:  B Plachter; S Klages; S Hagelmann; W Britt; M P Landini; G Jahn
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

8.  Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.

Authors:  J Basson; J C Tardy; M Aymard
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Demonstration of cytomegalovirus by polymerase chain reaction after liver transplantation.

Authors:  C A Schmidt; H Oettle; P Neuhaus; M Wiens; H Timm; F Wilborn; W Siegert
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

10.  Cloning of the complete human cytomegalovirus genome in cosmids.

Authors:  B Fleckenstein; I Müller; J Collins
Journal:  Gene       Date:  1982-04       Impact factor: 3.688

View more
  18 in total

1.  Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays.

Authors:  T Lazzarotto; S Brojanac; G T Maine; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens.

Authors:  G T Maine; T Lazzarotto; L E Chovan; R Flanders; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

3.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Authors:  G T Maine; R Stricker; M Schuler; J Spesard; S Brojanac; B Iriarte; K Herwig; T Gramins; B Combs; J Wise; H Simmons; T Gram; J Lonze; D Ruzicki; B Byrne; J D Clifton; L E Chovan; D Wachta; C Holas; D Wang; T Wilson; S Tomazic-Allen; M A Clements; G L Wright; T Lazzarotto; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.

Authors:  D Lang; R Vornhagen; M Rothe; W Hinderer; H H Sonneborn; B Plachter
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

6.  Reactivity to p52 and CM2 recombinant proteins in primary human cytomegalovirus infection with a microparticle agglutination assay.

Authors:  E Nulens; M Bodéus; F Bonelli; A Soleti; P Goubau
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

7.  Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.

Authors:  M Ohlin; B Plachter; V A Sundqvist; P G Steenbakkers; J M Middeldorp; C A Borrebaeck
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

8.  Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  A Tiran; R A Tio; E Oostenveld; M C Harmsen; B Tiran; P Den Heijer; S H Monnink; M M Wilders-Truschnig; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

9.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 10.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.